Similar articles

• A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.

  Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW. Feagan BG, et al. N Engl J Med. 2000 Jun 1;342(22):1627-32. doi: 10.1056/NEJM200006013422202. N Engl J Med. 2000. PMID: 10833208 Clinical Trial.
• Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?

  Charpignon C, Beau P. Charpignon C, et al. Gastroenterol Clin Biol. 2008 Feb;32(2):153-7. doi: 10.1016/j.gcb.2007.11.011. Epub 2008 Mar 17. Gastroenterol Clin Biol. 2008. PMID: 18343615
• The safety and tolerability of methotrexate for treating patients with Crohn's disease.

  Chande N, Abdelgadir I, Gregor J. Chande N, et al. J Clin Gastroenterol. 2011 Aug;45(7):599-601. doi: 10.1097/MCG.0b013e3181f593f9. J Clin Gastroenterol. 2011. PMID: 21224737 Review.
• Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.

  Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y. Weiss B, et al. J Pediatr Gastroenterol Nutr. 2009 May;48(5):526-30. doi: 10.1097/MPG.0b013e318196df3e. J Pediatr Gastroenterol Nutr. 2009. PMID: 19412004
• Immunosuppressive drugs in the treatment of Crohn's disease.

  Rutgeerts P, Baert F. Rutgeerts P, et al. Eur J Surg. 1998 Dec;164(12):911-5. doi: 10.1080/110241598750005075. Eur J Surg. 1998. PMID: 10029386 Review. No abstract available.